Analysts Set Definitive Healthcare Corp. (NASDAQ:DH) Target Price at $3.94

Definitive Healthcare Corp. (NASDAQ:DH) has been given an average recommendation of “Hold” by the nine research firms that are covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a sell rating, four have given a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $3.5214.

A number of equities research analysts have issued reports on the company. Stephens cut their target price on Definitive Healthcare from $3.00 to $2.00 and set an “equal weight” rating on the stock in a research note on Friday. Weiss Ratings reiterated a “sell (d-)” rating on shares of Definitive Healthcare in a research report on Wednesday, January 21st. William Blair upgraded shares of Definitive Healthcare to a “strong-buy” rating in a research note on Thursday, November 6th. Barclays cut their price target on Definitive Healthcare from $3.00 to $2.75 and set an “underweight” rating on the stock in a report on Monday, December 8th. Finally, Morgan Stanley restated an “underperform” rating and issued a $3.50 target price on shares of Definitive Healthcare in a research report on Thursday, December 18th.

Key Stories Impacting Definitive Healthcare

Here are the key news stories impacting Definitive Healthcare this week:

• Positive Sentiment: Q4 revenue came in roughly in-line to slightly above estimates (reported ~$61.5M vs. some analyst estimates around $59–61M), showing top-line stability versus a year ago. Read More.
• Positive Sentiment: Cash and cash equivalents increased year-over-year (reported ~$163.6M), which supports near-term liquidity. Read More.
• Neutral Sentiment: Reported GAAP EPS results were reported as meeting some consensus figures (sources show EPS in-line with a $0.06 consensus), so headline EPS didn’t surprise to the upside. Read More.
• Neutral Sentiment: Brokerage consensus has settled around a “Hold” average recommendation, reflecting mixed views across analysts. Read More.
• Negative Sentiment: The company cut guidance: Q1 FY2026 EPS guidance (~$0.03) and revenue guidance ($54M–$56M) both sit below consensus, and full‑year 2026 guidance ($0.14–$0.17 EPS; $220M–$226M revenue) also trails Street expectations — the primary driver of today’s downside. Read More.
• Negative Sentiment: Analysts lowered price targets and kept cautious ratings (Canaccord cut its target from $4.00 to $3.00 with a Hold; Stephens trimmed its target to $2.00 with Equal Weight), amplifying selling pressure. Read More.
• Negative Sentiment: Underlying profitability metrics showed deterioration in some reports (wider operating loss and larger net loss year-over-year), and multiple institutional holders trimmed positions in the latest quarter, suggesting reduced confidence from larger investors. Read More.

Definitive Healthcare Stock Down 8.6%

NASDAQ:DH opened at $1.28 on Friday. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.41. The stock has a 50 day moving average of $2.18 and a 200-day moving average of $2.87. The firm has a market capitalization of $180.94 million, a PE ratio of -1.02 and a beta of 1.66. Definitive Healthcare has a 52 week low of $1.14 and a 52 week high of $4.70.

Hedge Funds Weigh In On Definitive Healthcare

A number of institutional investors and hedge funds have recently bought and sold shares of DH. Goldman Sachs Group Inc. increased its stake in Definitive Healthcare by 564.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 8,716,725 shares of the company’s stock valued at $25,191,000 after buying an additional 7,404,363 shares during the period. Arrowstreet Capital Limited Partnership acquired a new position in shares of Definitive Healthcare during the second quarter valued at approximately $4,247,000. Inspire Investing LLC raised its holdings in Definitive Healthcare by 505.7% during the fourth quarter. Inspire Investing LLC now owns 698,967 shares of the company’s stock worth $2,006,000 after purchasing an additional 583,562 shares in the last quarter. Millennium Management LLC lifted its position in Definitive Healthcare by 230.9% in the fourth quarter. Millennium Management LLC now owns 332,087 shares of the company’s stock worth $953,000 after purchasing an additional 231,743 shares during the period. Finally, Jane Street Group LLC boosted its stake in Definitive Healthcare by 212.4% during the 2nd quarter. Jane Street Group LLC now owns 328,410 shares of the company’s stock valued at $1,281,000 after purchasing an additional 223,296 shares in the last quarter. Institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Company Profile

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.